| Name | Title | Contact Details |
|---|
EyeSee is a tech-enabled consumer research partner, providing highly predictive insights for shopper, advertising, innovation, and e-commerce optimization. Equipped with cross-category knowledge, our team is 150+ multidisciplinary experts strong and driven by passion to understand and help businesses grow. Join the ranks of top-tier CPG companies, healthcare innovators, and media trailblazers who trust EyeSees proven formula to navigate todays complex market dynamics with confidence. Three pillars of our research approach: 1. Comprehensive Insights: We employ a sophisticated mix-method approach, blending implicit and explicit methodologies to deliver 360-degree insights with high predictive power. 2. Realistic Testing Environments: Harnessing the prowess of our agile in-house design teams, we create lifelike virtual simulations of stores, social media platforms, and e-commerce sites. These simulated environments enable us to capture the subtlest and most authentic consumer behaviors. 3. Personalized Guidance: Our dedicated insights experts serve as your strategic partners, synthesizing data into actionable recommendations that drive tangible results. With our award-winning framework as the backbone, we lead studies spanning 50+ countries, stationed strategically in key hubs like New York, London, Paris, Antwerp, Mexico City, Belgrade, and Singapore. Among our most sought-after solutions are tests designed for packaging, planograms, claims, social media ads, TV commercials (TVCs), and e-commerce websites. Understand behavior, grow further!
Applied Direct Services Corporation is a Toronto, ON-based company in the Business Services sector.
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The companys initial focus is on a pipeline of oral, selective small molecule inhibitors of lymphocyte homing integrin α4β7 for IBD, a mechanism already validated by a commercially available antibody. Enshos assets were acquired from EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., that is focused on gastrointestinal disease. Ensho is preparing to initiate a Phase 2 clinical program in UC with NSHO-101, the lead asset in the companys pipeline.
We own and operate assisted living and memory care communities in Oregon and Arizona designed to keep seniors engaged, families connected, and communities whole.
Greatarrivals Com is a Attleboro, MA-based company in the Business Services sector.